Summary

The global Drug Delivery CDMO Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Drug delivery CDMO services often refer to contract development and manufacturing organizations (CDMOs) in drug development and production. These service providers focus on providing a range of services to pharmaceutical companies, including R&D and manufacturing services in drug delivery. Drug delivery refers to guiding drugs into the patient"s body through different routes to improve the therapeutic effect or improve the patient"s medication experience.
In 2025, the North America Drug Delivery CDMO Services market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Drug Delivery CDMO Services include Evonik Health Care, Sanner, Lubrizol Life Science Health (LLS Health), Kindeva Drug Delivery, Beijing TheraXyte Biotechnology, Altasciences, Stevanato Group, RiboBio, Lonza, Thermo Fisher Scientific, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Drug Delivery CDMO Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Evonik Health Care
Sanner
Lubrizol Life Science Health (LLS Health)
Kindeva Drug Delivery
Beijing TheraXyte Biotechnology
Altasciences
Stevanato Group
RiboBio
Lonza
Thermo Fisher Scientific
Catalent
Asymchem
Samsung Biologics
CD Bioarticles
Segment by Type
In Vivo Delivery
In Vitro Delivery
Segment by Application
Macromolecule Drugs
Small Molecule Drug
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Drug Delivery CDMO Services market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drug Delivery CDMO Services value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 In Vivo Delivery
1.2.3 In Vitro Delivery
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Macromolecule Drugs
1.3.3 Small Molecule Drug
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Drug Delivery CDMO Services Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Drug Delivery CDMO Services Market Share by Revenue, by Region (2021-2026)
2.4 Global Drug Delivery CDMO Services Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Drug Delivery CDMO Services Market Size and Prospective (2021-2032)
2.5.2 Europe Drug Delivery CDMO Services Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Drug Delivery CDMO Services Market Size and Prospective (2021-2032)
2.5.4 Latin America Drug Delivery CDMO Services Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Drug Delivery CDMO Services Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Drug Delivery CDMO Services Historical Market Size by Type (2021-2026)
3.2 Global Drug Delivery CDMO Services Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Drug Delivery CDMO Services

4 Breakdown Data by Application
4.1 Global Drug Delivery CDMO Services Historical Market Size by Application (2021-2026)
4.2 Global Drug Delivery CDMO Services Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Drug Delivery CDMO Services Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Drug Delivery CDMO Services Players by Revenue (2021-2026)
5.1.2 Global Drug Delivery CDMO Services Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Drug Delivery CDMO Services Revenue
5.4 Global Drug Delivery CDMO Services Market Concentration Analysis
5.4.1 Global Drug Delivery CDMO Services Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Drug Delivery CDMO Services Revenue in 2025
5.5 Global Key Players of Drug Delivery CDMO Services Head Offices and Areas Served
5.6 Global Key Players of Drug Delivery CDMO Services, Product and Application
5.7 Global Key Players of Drug Delivery CDMO Services, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Drug Delivery CDMO Services Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Drug Delivery CDMO Services Market Size by Type (2021-2026)
6.1.2.2 North America Drug Delivery CDMO Services Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Drug Delivery CDMO Services Market Size by Application (2021-2026)
6.1.3.2 North America Drug Delivery CDMO Services Market Share by Application (2021-2026)
6.1.4 North America Drug Delivery CDMO Services Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Drug Delivery CDMO Services Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Drug Delivery CDMO Services Market Size by Type (2021-2026)
6.2.2.2 Europe Drug Delivery CDMO Services Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Drug Delivery CDMO Services Market Size by Application (2021-2026)
6.2.3.2 Europe Drug Delivery CDMO Services Market Share by Application (2021-2026)
6.2.4 Europe Drug Delivery CDMO Services Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Drug Delivery CDMO Services Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Drug Delivery CDMO Services Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Drug Delivery CDMO Services Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Drug Delivery CDMO Services Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Drug Delivery CDMO Services Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Drug Delivery CDMO Services Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Drug Delivery CDMO Services Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Drug Delivery CDMO Services Market Size by Type (2021-2026)
6.4.2.2 Latin America Drug Delivery CDMO Services Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Drug Delivery CDMO Services Market Size by Application (2021-2026)
6.4.3.2 Latin America Drug Delivery CDMO Services Market Share by Application (2021-2026)
6.4.4 Latin America Drug Delivery CDMO Services Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Drug Delivery CDMO Services Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Drug Delivery CDMO Services Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Drug Delivery CDMO Services Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Drug Delivery CDMO Services Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Drug Delivery CDMO Services Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Drug Delivery CDMO Services Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 Evonik Health Care
7.1.1 Evonik Health Care Company Details
7.1.2 Evonik Health Care Business Overview
7.1.3 Evonik Health Care Drug Delivery CDMO Services Introduction
7.1.4 Evonik Health Care Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.1.5 Evonik Health Care Recent Development
7.2 Sanner
7.2.1 Sanner Company Details
7.2.2 Sanner Business Overview
7.2.3 Sanner Drug Delivery CDMO Services Introduction
7.2.4 Sanner Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.2.5 Sanner Recent Development
7.3 Lubrizol Life Science Health (LLS Health)
7.3.1 Lubrizol Life Science Health (LLS Health) Company Details
7.3.2 Lubrizol Life Science Health (LLS Health) Business Overview
7.3.3 Lubrizol Life Science Health (LLS Health) Drug Delivery CDMO Services Introduction
7.3.4 Lubrizol Life Science Health (LLS Health) Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.3.5 Lubrizol Life Science Health (LLS Health) Recent Development
7.4 Kindeva Drug Delivery
7.4.1 Kindeva Drug Delivery Company Details
7.4.2 Kindeva Drug Delivery Business Overview
7.4.3 Kindeva Drug Delivery Drug Delivery CDMO Services Introduction
7.4.4 Kindeva Drug Delivery Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.4.5 Kindeva Drug Delivery Recent Development
7.5 Beijing TheraXyte Biotechnology
7.5.1 Beijing TheraXyte Biotechnology Company Details
7.5.2 Beijing TheraXyte Biotechnology Business Overview
7.5.3 Beijing TheraXyte Biotechnology Drug Delivery CDMO Services Introduction
7.5.4 Beijing TheraXyte Biotechnology Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.5.5 Beijing TheraXyte Biotechnology Recent Development
7.6 Altasciences
7.6.1 Altasciences Company Details
7.6.2 Altasciences Business Overview
7.6.3 Altasciences Drug Delivery CDMO Services Introduction
7.6.4 Altasciences Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.6.5 Altasciences Recent Development
7.7 Stevanato Group
7.7.1 Stevanato Group Company Details
7.7.2 Stevanato Group Business Overview
7.7.3 Stevanato Group Drug Delivery CDMO Services Introduction
7.7.4 Stevanato Group Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.7.5 Stevanato Group Recent Development
7.8 RiboBio
7.8.1 RiboBio Company Details
7.8.2 RiboBio Business Overview
7.8.3 RiboBio Drug Delivery CDMO Services Introduction
7.8.4 RiboBio Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.8.5 RiboBio Recent Development
7.9 Lonza
7.9.1 Lonza Company Details
7.9.2 Lonza Business Overview
7.9.3 Lonza Drug Delivery CDMO Services Introduction
7.9.4 Lonza Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.9.5 Lonza Recent Development
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Company Details
7.10.2 Thermo Fisher Scientific Business Overview
7.10.3 Thermo Fisher Scientific Drug Delivery CDMO Services Introduction
7.10.4 Thermo Fisher Scientific Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.10.5 Thermo Fisher Scientific Recent Development
7.11 Catalent
7.11.1 Catalent Company Details
7.11.2 Catalent Business Overview
7.11.3 Catalent Drug Delivery CDMO Services Introduction
7.11.4 Catalent Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.11.5 Catalent Recent Development
7.12 Asymchem
7.12.1 Asymchem Company Details
7.12.2 Asymchem Business Overview
7.12.3 Asymchem Drug Delivery CDMO Services Introduction
7.12.4 Asymchem Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.12.5 Asymchem Recent Development
7.13 Samsung Biologics
7.13.1 Samsung Biologics Company Details
7.13.2 Samsung Biologics Business Overview
7.13.3 Samsung Biologics Drug Delivery CDMO Services Introduction
7.13.4 Samsung Biologics Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.13.5 Samsung Biologics Recent Development
7.14 CD Bioarticles
7.14.1 CD Bioarticles Company Details
7.14.2 CD Bioarticles Business Overview
7.14.3 CD Bioarticles Drug Delivery CDMO Services Introduction
7.14.4 CD Bioarticles Revenue in Drug Delivery CDMO Services Business (2021-2026)
7.14.5 CD Bioarticles Recent Development

8 Drug Delivery CDMO Services Market Dynamics
8.1 Drug Delivery CDMO Services Industry Trends
8.2 Drug Delivery CDMO Services Market Drivers
8.3 Drug Delivery CDMO Services Market Challenges
8.4 Drug Delivery CDMO Services Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Drug Delivery CDMO Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Drug Delivery CDMO Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Drug Delivery CDMO Services Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Drug Delivery CDMO Services Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Drug Delivery CDMO Services Revenue Share by Region (2021-2026)
Table 6. Global Drug Delivery CDMO Services Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Drug Delivery CDMO Services Revenue Share Forecast by Region (2027-2032)
Table 8. Global Drug Delivery CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Drug Delivery CDMO Services Market Share by Revenue, by Type (2021-2026)
Table 10. Global Drug Delivery CDMO Services Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Drug Delivery CDMO Services Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Drug Delivery CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Drug Delivery CDMO Services Market Share by Revenue, by Application (2021-2026)
Table 15. Global Drug Delivery CDMO Services Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Drug Delivery CDMO Services Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Drug Delivery CDMO Services Applications
Table 18. Global Drug Delivery CDMO Services Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Drug Delivery CDMO Services Market Share by Players (2021-2026)
Table 20. Global Top Drug Delivery CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery CDMO Services as of 2025)
Table 21. Ranking of Global Top Drug Delivery CDMO Services Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Drug Delivery CDMO Services Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Drug Delivery CDMO Services, Headquarters and Area Served
Table 24. Global Key Players of Drug Delivery CDMO Services, Product and Application
Table 25. Global Key Players of Drug Delivery CDMO Services, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Drug Delivery CDMO Services Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Drug Delivery CDMO Services Market Share by Revenue, by Company (2021-2026)
Table 29. North America Drug Delivery CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Drug Delivery CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Drug Delivery CDMO Services Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Drug Delivery CDMO Services Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Drug Delivery CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Drug Delivery CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Drug Delivery CDMO Services Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Drug Delivery CDMO Services Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Drug Delivery CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Drug Delivery CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Drug Delivery CDMO Services Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Drug Delivery CDMO Services Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Drug Delivery CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Drug Delivery CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Drug Delivery CDMO Services Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Drug Delivery CDMO Services Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Drug Delivery CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Drug Delivery CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 47. Evonik Health Care Company Details
Table 48. Evonik Health Care Business Overview
Table 49. Evonik Health Care Drug Delivery CDMO Services Product
Table 50. Evonik Health Care Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 51. Evonik Health Care Recent Development
Table 52. Sanner Company Details
Table 53. Sanner Business Overview
Table 54. Sanner Drug Delivery CDMO Services Product
Table 55. Sanner Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 56. Sanner Recent Development
Table 57. Lubrizol Life Science Health (LLS Health) Company Details
Table 58. Lubrizol Life Science Health (LLS Health) Business Overview
Table 59. Lubrizol Life Science Health (LLS Health) Drug Delivery CDMO Services Product
Table 60. Lubrizol Life Science Health (LLS Health) Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 61. Lubrizol Life Science Health (LLS Health) Recent Development
Table 62. Kindeva Drug Delivery Company Details
Table 63. Kindeva Drug Delivery Business Overview
Table 64. Kindeva Drug Delivery Drug Delivery CDMO Services Product
Table 65. Kindeva Drug Delivery Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 66. Kindeva Drug Delivery Recent Development
Table 67. Beijing TheraXyte Biotechnology Company Details
Table 68. Beijing TheraXyte Biotechnology Business Overview
Table 69. Beijing TheraXyte Biotechnology Drug Delivery CDMO Services Product
Table 70. Beijing TheraXyte Biotechnology Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 71. Beijing TheraXyte Biotechnology Recent Development
Table 72. Altasciences Company Details
Table 73. Altasciences Business Overview
Table 74. Altasciences Drug Delivery CDMO Services Product
Table 75. Altasciences Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 76. Altasciences Recent Development
Table 77. Stevanato Group Company Details
Table 78. Stevanato Group Business Overview
Table 79. Stevanato Group Drug Delivery CDMO Services Product
Table 80. Stevanato Group Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 81. Stevanato Group Recent Development
Table 82. RiboBio Company Details
Table 83. RiboBio Business Overview
Table 84. RiboBio Drug Delivery CDMO Services Product
Table 85. RiboBio Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 86. RiboBio Recent Development
Table 87. Lonza Company Details
Table 88. Lonza Business Overview
Table 89. Lonza Drug Delivery CDMO Services Product
Table 90. Lonza Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 91. Lonza Recent Development
Table 92. Thermo Fisher Scientific Company Details
Table 93. Thermo Fisher Scientific Business Overview
Table 94. Thermo Fisher Scientific Drug Delivery CDMO Services Product
Table 95. Thermo Fisher Scientific Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 96. Thermo Fisher Scientific Recent Development
Table 97. Catalent Company Details
Table 98. Catalent Business Overview
Table 99. Catalent Drug Delivery CDMO Services Product
Table 100. Catalent Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 101. Catalent Recent Development
Table 102. Asymchem Company Details
Table 103. Asymchem Business Overview
Table 104. Asymchem Drug Delivery CDMO Services Product
Table 105. Asymchem Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 106. Asymchem Recent Development
Table 107. Samsung Biologics Company Details
Table 108. Samsung Biologics Business Overview
Table 109. Samsung Biologics Drug Delivery CDMO Services Product
Table 110. Samsung Biologics Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 111. Samsung Biologics Recent Development
Table 112. CD Bioarticles Company Details
Table 113. CD Bioarticles Business Overview
Table 114. CD Bioarticles Drug Delivery CDMO Services Product
Table 115. CD Bioarticles Revenue in Drug Delivery CDMO Services Business (2021-2026) & (US$ Million)
Table 116. CD Bioarticles Recent Development
Table 117. Drug Delivery CDMO Services Market Trends
Table 118. Drug Delivery CDMO Services Market Drivers
Table 119. Drug Delivery CDMO Services Market Challenges
Table 120. Drug Delivery CDMO Services Market Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources

List of Figures
Figure 1. Drug Delivery CDMO Services Product Picture
Figure 2. Global Drug Delivery CDMO Services Market Share by Type: 2025 vs 2032
Figure 3. In Vivo Delivery Features
Figure 4. In Vitro Delivery Features
Figure 5. Global Drug Delivery CDMO Services Market Share by Application: 2025 vs 2032
Figure 6. Macromolecule Drugs
Figure 7. Small Molecule Drug
Figure 8. Others
Figure 9. Drug Delivery CDMO Services Report Years Considered
Figure 10. Global Drug Delivery CDMO Services Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 11. Global Drug Delivery CDMO Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Drug Delivery CDMO Services Market Share by Revenue, by Region: 2021 vs 2025
Figure 13. North America Drug Delivery CDMO Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 14. Europe Drug Delivery CDMO Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Asia-Pacific Drug Delivery CDMO Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Latin America Drug Delivery CDMO Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Middle East & Africa Drug Delivery CDMO Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Global Drug Delivery CDMO Services Market Share by Players in 2025
Figure 19. Global Top Drug Delivery CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery CDMO Services as of 2025)
Figure 20. The Top 10 and 5 Players Market Share by Drug Delivery CDMO Services Revenue in 2025
Figure 21. North America Drug Delivery CDMO Services Market Share by Type (2021-2026)
Figure 22. North America Drug Delivery CDMO Services Market Share by Application (2021-2026)
Figure 23. Europe Drug Delivery CDMO Services Market Share by Type (2021-2026)
Figure 24. Europe Drug Delivery CDMO Services Market Share by Application (2021-2026)
Figure 25. Asia-Pacific Drug Delivery CDMO Services Market Share by Type (2021-2026)
Figure 26. Asia-Pacific Drug Delivery CDMO Services Market Share by Application (2021-2026)
Figure 27. Latin America Drug Delivery CDMO Services Market Share by Type (2021-2026)
Figure 28. Latin America Drug Delivery CDMO Services Market Share by Application (2021-2026)
Figure 29. Middle East & Africa Drug Delivery CDMO Services Market Share by Type (2021-2026)
Figure 30. Middle East & Africa Drug Delivery CDMO Services Market Share by Application (2021-2026)
Figure 31. Evonik Health Care Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 32. Sanner Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 33. Lubrizol Life Science Health (LLS Health) Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 34. Kindeva Drug Delivery Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 35. Beijing TheraXyte Biotechnology Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 36. Altasciences Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 37. Stevanato Group Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 38. RiboBio Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 39. Lonza Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 40. Thermo Fisher Scientific Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 41. Catalent Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 42. Asymchem Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 43. Samsung Biologics Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 44. CD Bioarticles Revenue Growth Rate in Drug Delivery CDMO Services Business (2021-2026)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed